1. Home
  2. CCCS vs BLCO Comparison

CCCS vs BLCO Comparison

Compare CCCS & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCS
  • BLCO
  • Stock Information
  • Founded
  • CCCS 1980
  • BLCO 1853
  • Country
  • CCCS United States
  • BLCO Canada
  • Employees
  • CCCS N/A
  • BLCO N/A
  • Industry
  • CCCS Computer Software: Prepackaged Software
  • BLCO Ophthalmic Goods
  • Sector
  • CCCS Technology
  • BLCO Health Care
  • Exchange
  • CCCS Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • CCCS 7.4B
  • BLCO 7.0B
  • IPO Year
  • CCCS N/A
  • BLCO 2022
  • Fundamental
  • Price
  • CCCS $12.47
  • BLCO $19.58
  • Analyst Decision
  • CCCS Buy
  • BLCO Buy
  • Analyst Count
  • CCCS 9
  • BLCO 11
  • Target Price
  • CCCS $13.78
  • BLCO $21.30
  • AVG Volume (30 Days)
  • CCCS 3.2M
  • BLCO 430.1K
  • Earning Date
  • CCCS 10-28-2024
  • BLCO 10-30-2024
  • Dividend Yield
  • CCCS N/A
  • BLCO N/A
  • EPS Growth
  • CCCS N/A
  • BLCO N/A
  • EPS
  • CCCS 0.07
  • BLCO N/A
  • Revenue
  • CCCS $926,937,000.00
  • BLCO $4,684,000,000.00
  • Revenue This Year
  • CCCS $11.08
  • BLCO $17.44
  • Revenue Next Year
  • CCCS $8.17
  • BLCO $6.18
  • P/E Ratio
  • CCCS $177.82
  • BLCO N/A
  • Revenue Growth
  • CCCS 10.10
  • BLCO 18.01
  • 52 Week Low
  • CCCS $9.79
  • BLCO $13.16
  • 52 Week High
  • CCCS $12.68
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • CCCS 76.40
  • BLCO 47.50
  • Support Level
  • CCCS $11.44
  • BLCO $19.31
  • Resistance Level
  • CCCS $12.00
  • BLCO $20.23
  • Average True Range (ATR)
  • CCCS 0.30
  • BLCO 0.48
  • MACD
  • CCCS 0.11
  • BLCO -0.10
  • Stochastic Oscillator
  • CCCS 95.01
  • BLCO 19.37

About CCCS CCC Intelligent Solutions Holdings Inc.

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. The company generate revenue through the sale of software subscriptions and other revenue, primarily from professional services. The company has its presence in United States and China. Majority of the revenue is generated from United States.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: